Market Narratives
Market themes driving price action · Updated Jul 25, 2026
BTE hedge fund favor and share buyback program
An article belongs to this narrative if it discusses Baytex Energy's hedge fund favor and share buyback program.
ALSN BAE Systems CV90 MkIV transmission contract
An article belongs to this narrative if it covers Allison Transmission's contract with BAE Systems for CV90 MkIV transmissions.
SITC divests stake in The Pike Outlets
An article belongs to this narrative if it discusses SITE Centers' divestment of its stake in The Pike Outlets.
ACH hedge fund favor and senior notes settlement
An article belongs to this narrative if it covers Accendra Health's hedge fund favor and senior notes settlement.
GGB hedge fund favor and bullish consensus
An article belongs to this narrative if it discusses Gerdau's hedge fund favor and bullish consensus.
LEGN nears adjusted profitability with CARVYKTI growth
An article belongs to this narrative if it discusses Legend Biotech's (LEGN) nearing adjusted profitability due to CARVYKTI growth.
Hershey US president appointment
An article belongs to this narrative if it discusses the appointment of a new US president at Hershey.
Upstream Bio's price target reduction
An article belongs to this narrative if it discusses the significant reduction in Upstream Bio's price target by JPMorgan.
Eli Lilly's vaccine acquisitions
An article belongs to this narrative if it discusses Eli Lilly's planned acquisitions of vaccine developers.
Fraud in politics: lack of interest until Trump
An article belongs to this narrative if it discusses political inaction on fraud until Trump.
Charlie Kirk assassination case
An article belongs to this narrative if it covers the legal case involving Charlie Kirk's alleged assassin, Tyler James Robinson.
ALHC business updates
An article belongs to this narrative if it discusses business updates or earnings from Alignment Healthcare.
Itoham Yonekyu acquires Greenlea Group
An article belongs to this narrative if it discusses acquisitions in the meat processing industry, with a focus on Itoham Yonekyu and Greenlea Group.
AppLovin applied AI winner
An article belongs to this narrative if it discusses AppLovin's application of AI.
ResMed OSA market expansion potential
An article belongs to this narrative if it discusses the potential for ResMed in the obstructive sleep apnea market.
Quantum Space CFO appointment
An article belongs to this narrative if it discusses the appointment of a new CFO at Quantum Space.
Visteon share repurchase program
An article belongs to this narrative if it discusses Visteon's share repurchase program.
QCOM Snapdragon Reality Elite platform launch
An article belongs to this narrative if it discusses Qualcomm's launch of the Snapdragon Reality Elite platform.
CLVT sells Life Sciences & Healthcare business to Altaris
An article belongs to this narrative if it discusses Clarivate's sale of its Life Sciences & Healthcare business to Altaris.
Mirum Pharmaceuticals positive Phase 2b data
An article belongs to this narrative if it discusses Mirum Pharmaceuticals' positive Phase 2b data for volixibat in PSC.
ALIT stock withers due to 1-for-20 reverse stock split
An article belongs to this narrative if it discusses ALIT's reverse stock split and its impact on the company's stock performance.
Edgewise Therapeutics positive HCM trial data
An article belongs to this narrative if it discusses positive trial data for Edgewise Therapeutics' hypertrophic cardiomyopathy treatment.
Rocket Pharmaceuticals gene therapy milestone
An article belongs to this narrative if it discusses a key milestone in Rocket Pharmaceuticals' gene therapy program.
Ocular Therapeutix FDA feedback on Axpaxli
An article belongs to this narrative if it discusses the FDA feedback on Ocular Therapeutix's Axpaxli product.